---
document_datetime: 2023-09-21 20:14:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/desloratadine-ratiopharm-epar-all-authorised-presentations_en.pdf
document_name: desloratadine-ratiopharm-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0644382
conversion_datetime: 2025-12-30 02:45:15.984112
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name          | Strength   | Pharmaceutical Form   | Route of administration   | Immediate Packaging    | Pack size   |
|------------------|--------------------------|------------|-----------------------|---------------------------|------------------------|-------------|
| EU/1/11/746/001  | Desloratadine ratiopharm | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 7 tablets   |
| EU/1/11/746/002  | Desloratadine ratiopharm | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 10 tablets  |
| EU/1/11/746/003  | Desloratadine ratiopharm | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 14 tablets  |
| EU/1/11/746/004  | Desloratadine ratiopharm | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 15 tablets  |
| EU/1/11/746/005  | Desloratadine ratiopharm | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 20 tablets  |
| EU/1/11/746/006  | Desloratadine ratiopharm | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 30 tablets  |